Cargando…

Investigation of time to first presentation and extrahospital factors in the treatment of neovascular age-related macular degeneration: a retrospective cross-sectional study

OBJECTIVES: To assess the time from symptom onset to treatment for neovascular age-related macular degeneration (nvAMD) and to measure the awareness of AMD in Southeast Scotland. DESIGN: Retrospective cross-sectional study. SETTING: Secondary care, Southeast of Scotland. METHODS: Patients treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sim, Peng Yong, Gajree, Sonul, Dhillon, Baljean, Borooah, Shyamanga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Ophthalmology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778287/ https://www.ncbi.nlm.nih.gov/pubmed/29229653 http://dx.doi.org/10.1136/bmjopen-2017-017771

Ejemplares similares

Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab
por: Elwes, Flora, et al.
Publicado: (2018)

Subretinal Neovascular Membrane in Wet Age-Related Macular Degeneration Managed With Intravitreal Ranibizumab
por: Sharma, Tanishq S, et al.
Publicado: (2021)

Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study
por: Jern, Iréne, et al.
Publicado: (2022)

Patient perspectives and barriers in the treatment of neovascular age-related macular degeneration in Denmark: a qualitative study
por: Thinggaard, Benjamin Sommer, et al.
Publicado: (2023)

Faricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration
por: Cheng, Anny M, et al.
Publicado: (2023)

Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model
por: Thomas, Darren S, et al.
Publicado: (2022)

Emotional and physical experiences of people with neovascular age-related macular degeneration during the injection process in Germany: a qualitative study
por: Thier, Anne, et al.
Publicado: (2022)

Incidence and prevalence of neovascular age-related macular degeneration: 15-year epidemiological study in a population-based cohort in Finland
por: Korva-Gurung, Ida, et al.
Publicado: (2023)

Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry
por: Riemer, Tommes, et al.
Publicado: (2023)

Comparative efficacy and safety of different regimens of ranibizumab for neovascular age-related macular degeneration: a network meta-analysis of randomised controlled trials
por: Zhao, Xinyu, et al.
Publicado: (2021)

Antiplatelet and anticoagulant therapy in patients with submacular hemorrhage caused by neovascular age-related macular degeneration
por: Weber, Constance, et al.
Publicado: (2022)

A Comparative Study of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration: 12-Month Outcomes of Polish Therapeutic Program in Non-Tertiary Institution
por: Skrzypczak, Tomasz, et al.
Publicado: (2021)

Self-Examination Low-Cost Full-Field Optical Coherence Tomography (SELFF-OCT) for neovascular age-related macular degeneration: a cross-sectional diagnostic accuracy study
por: von der Burchard, Claus, et al.
Publicado: (2022)

Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration
por: Dikmetas, Ozlem, et al.
Publicado: (2022)

Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)

Effectiveness of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual non-inferiority trial
por: Reeves, Barnaby C, et al.
Publicado: (2016)

Repeatability of retinal thickness and volume metrics in neovascular age-related macular degeneration using the topcon 3doct-1000
por: Tah, Vikas, et al.
Publicado: (2014)

FENETRE study: quality-assured follow-up of quiescent neovascular age-related macular degeneration by non-medical practitioners: study protocol and statistical analysis plan for a randomised controlled trial
por: Learoyd, Annastazia E, et al.
Publicado: (2021)

Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment
por: Vyawahare, Hrishikesh, et al.
Publicado: (2022)

Safety and efficacy of an artificial intelligence-enabled decision tool for treatment decisions in neovascular age-related macular degeneration and an exploration of clinical pathway integration and implementation: protocol for a multi-methods validation study
por: Hogg, Henry David Jeffry, et al.
Publicado: (2023)

Association between metformin use and the risk of age-related macular degeneration in patients with type 2 diabetes: a retrospective study
por: Jiang, Jingjing, et al.
Publicado: (2022)

Deep Learning Classification of Drusen, Choroidal Neovascularization, and Diabetic Macular Edema in Optical Coherence Tomography (OCT) Images
por: Riazi Esfahani, Parsa, et al.
Publicado: (2023)

Suspected Neratinib Macular Toxicity Presenting As Macular Telangiectasia Type II
por: Enghelberg, Moises, et al.
Publicado: (2023)

TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands
por: Foss, Alexander, et al.
Publicado: (2020)

Healthcare experiences of patients with age-related macular degeneration: have things improved? Cross-sectional survey responses of Macular Society members in 2013 compared with 1999
por: Boxell, Emily M, et al.
Publicado: (2017)

An Analysis of the Usage of Retinal Imaging Technology in the Detection of Age-Related Macular Degeneration
por: Riazi Esfahani, Parsa, et al.
Publicado: (2023)

Cross-sectional study evaluating burden and depressive symptoms in family carers of persons with age-related macular degeneration in Australia
por: Jin, Ivan, et al.
Publicado: (2021)

One- and two-year visual outcomes from the Moorfields age-related macular degeneration database: a retrospective cohort study and an open science resource
por: Fasler, Katrin, et al.
Publicado: (2019)

Late-Onset Retinal Degeneration: Clinical Perspectives
por: Lando, Leonardo, et al.
Publicado: (2022)

Evaluation of the effect of intravitreal ranibizumab injections in patients with neovascular age related macular degeneration on retinal nerve fiber layer thickness using optical coherence tomography
por: El-Ashry, Mohamed F, et al.
Publicado: (2015)

Dietary intervention in patients with age-related macular degeneration: protocol for a randomised controlled trial
por: Tang, Diana, et al.
Publicado: (2019)

A Study of Correlates of Age-Related Macular Degeneration in Patients Attending a Tertiary Hospital
por: Mehta, Kervi, et al.
Publicado: (2022)

Age-Related Macular Degeneration: An Exponentially Emerging Imminent Threat of Visual Impairment and Irreversible Blindness
por: Chaudhuri, Madhurima, et al.
Publicado: (2023)

Spectral domain-optical coherence tomography retinal biomarkers in choroidal neovascularization of multifocal choroiditis, myopic choroidal neovascularization, and idiopathic choroidal neovascularization
por: Gao, Rui, et al.
Publicado: (2021)

Cross-sectional study of the association between age-related macular degeneration and arthritis in the National Health and Nutrition Examination Survey 2005–2008
por: Zhu, Zhuoting, et al.
Publicado: (2020)

Prevalence and Associated Risk Factors of Age-Related Macular Degeneration in the Retina Clinic at a Tertiary Center in Makkah Province, Saudi Arabia: A Retrospective Record Review
por: Abusharkh, Fatmah H, et al.
Publicado: (2023)

Co-existence of Age-Related Macular Degeneration and Diabetic Retinopathy in a Tertiary Referral Center in Greece
por: Bourouki, Evgenia, et al.
Publicado: (2022)

Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
por: Yiallouridou, Christina, et al.
Publicado: (2023)

Anti-VEGF therapies in the treatment of choroidal neovascularisation secondary to non-age-related macular degeneration: a systematic review
por: Stuart, Arabella, et al.
Publicado: (2015)

Patient experience of treatment decision making for wet age-related macular degeneration disease: a qualitative study in China
por: Bian, Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lfr1i7ee7fadbdhcck9r0r3jql